BRIEF-Glenmark Generics confirms patent challenge for its generic version of FINACEA

March 14 (Reuters) - Glenmark Pharmaceuticals Ltd :

* Glenmark confirms patent challenge for its generic version of FINACEA

* Intendis,Intraserv and Bayer Healthcare filed suit against Glenmark Generics

seeking to prevent sales of ANDA product

* Source text: * Further company coverage

((Bangalore Newsroom; +91 4135 5800))

View the original article here